Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.

In conclusion, synergistic combination of doxorubicin and paclitaxel delivered by the TF/TAT-LP could efficiently target to the brain glioma with satisfying treatment efficiency, which may be a promising formulation for glioma therapy. PMID: 27033513 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/27033513?dopt=Abstract

Source: Current Pharmaceutical Biotechnology - March 31, 2016 Category: Biotechnology Authors: Chen X, Yuan M, Zhang Q, Yang Y, Gao H, He Q Tags: Curr Pharm Biotechnol Source Type: research